Loss of astrocytic markers and impaired metabolic function in spinocerebellar ataxia type 7 patient-derived neural cultures
Neurobiology of Disease · 2026
DOI: 10.1016/j.nbd.2026.107477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2026. Verfasst von Linde F Bouwman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. Hauptthemen laut MEDLINE: Spinocerebellar Ataxias, Astrocytes, Induced Pluripotent Stem Cells, Neurons. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain Foundation.
Abstract (Originalsprache)
Spinocerebellar ataxia type 7 (SCA7) is a rare neurodegenerative disorder caused by a CAG repeat expansion in the ATXN7 gene. This repeat expansion results in an abnormally long polyglutamine (PolyQ) tract in the Ataxin-7 protein. This ultimately leads to the degeneration of most notably Purkinje cells and retinal cells. Because no treatment exist that can halt or slow disease progression, there is a critical need for patient-specific disease models to uncover new pathogenic mechanisms and enable therapeutic testing. In this study, induced human pluripotent stem cells (hiPSCs) derived from healthy controls and individuals with SCA7 were differentiated into a mixed neural cell population consisting of neurons and astrocytes. Although control and SCA7 neurons appeared morphologically similar, SCA7-derived astrocytes exhibited a pronounced loss of the astrocyte-specific markers GFAP and S100B. Transcriptome analysis revealed substantial alterations in genes related to glial differentiation, cellular metabolism and oxygen handling, protein homeostasis, and neuronal differentiation and neuronal signalling. Mitochondrial stress assays further confirmed a mitochondrial phenotype in SCA7 neural cells. Together, these findings demonstrate that hiPSC-derived neural cells provide a robust platform that can be used for studying disease mechanisms and testing potential therapies for SCA7.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
- Department of Biomedical Data Sciences, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
- Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands. Electronic address: W.M.C.van_Roon@lumc.nl.
Förderung
- Brain Foundation
Zitieren
APA
Bouwman, L. F., Buijsen, R. A. M., van der Graaf, L. M., Pepers, B. A., Voesenek, B. J. B., Mei, H., van de Warrenburg, B. P. C., & van Roon-Mom, W. M. C. (2026). Loss of astrocytic markers and impaired metabolic function in spinocerebellar ataxia type 7 patient-derived neural cultures. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2026.107477
Vancouver
Bouwman LF, Buijsen RAM, van der Graaf LM, Pepers BA, Voesenek BJB, Mei H, et al. Loss of astrocytic markers and impaired metabolic function in spinocerebellar ataxia type 7 patient-derived neural cultures. Neurobiology of Disease. 2026. doi:10.1016/j.nbd.2026.107477
BibTeX
@article{Bouwman2026,
author = {Bouwman, Linde F and Buijsen, Ronald A M and van der Graaf, Linda M and Pepers, Barry A and Voesenek, Bas J B and Mei, Hailiang and van de Warrenburg, Bart P C and van Roon-Mom, Willeke M C},
title = {Loss of astrocytic markers and impaired metabolic function in spinocerebellar ataxia type 7 patient-derived neural cultures},
journal = {Neurobiology of Disease},
year = {2026},
doi = {10.1016/j.nbd.2026.107477}
}
EUVIMED